Compare RANI & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | SUNS |
|---|---|---|
| Founded | 2012 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 126.3M |
| IPO Year | 2021 | N/A |
| Metric | RANI | SUNS |
|---|---|---|
| Price | $1.07 | $8.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $8.50 | ★ $8.75 |
| AVG Volume (30 Days) | ★ 925.4K | 83.0K |
| Earning Date | 05-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 14.44% |
| EPS Growth | ★ 21.05 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,028,000.00 | N/A |
| Revenue This Year | $414.59 | $91.00 |
| Revenue Next Year | $30.15 | $20.79 |
| P/E Ratio | ★ N/A | $8.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $7.80 |
| 52 Week High | $3.87 | $11.78 |
| Indicator | RANI | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 36.41 | 36.93 |
| Support Level | $1.07 | N/A |
| Resistance Level | $1.54 | $9.69 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 17.14 | 27.03 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.